GL1X · GenesisL1 explorer

MolNFT v1 · #90160 · protein

Hyperstable in-frame insertion variant of antithrombin

4EB1 · Antithrombin-III: “Hyperstable in-frame insertion variant of antithrombin”. X-ray diffraction, 1 ligand (NAG), 9 pockets (best druggability 0.74). MolNFT v1 #90160 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4EB1
Type
protein
Length
803 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antithrombin-III
UniProt
P01008
Ligands
NAG
Pockets
9 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
IAntithrombin-IIIprotein41131% helix, 35% strandP01008
LAntithrombin-IIIprotein39231% helix, 33% strandP01008

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains I, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16660.740.8067empty
2560.620.9317empty
3570.500.8617empty
4570.490.8518empty
5640.380.7918empty

Interfaces

1 interface between chains.

  • I–L · 834 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 4EB1 · Hyperstable in-frame insertion variant of antithrombin · the same entry in another collection · chain I against I, TM-score 1.00
  • P01008 · AlphaFold monomer V2.0 prediction for antithrombin-III (P01008) · a predicted model of the same protein · chain L against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.